APPLE ROBERT F
Insider CIK 1054942 · AIS President and CEO, Director · KZIA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KZIA KAZIA THERAPEUTICS LTD | A Award deriv | 2026-01-08 | 2026-07-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 776,617 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 567,423 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 591,510 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 725,751 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 773,700 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 288,786 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 21,658 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 474,629 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 56,300 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 374,099 | $5.60 | $2.09M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 611,667 | $5.60 | $3.43M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 1,876,693 | $5.60 | $10.51M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-03-03 | 2022-03-04 | 86,814 | — | $0 | 2,526,055 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-03-03 | 2022-03-04 | 37,695 | $3.80 | $143.2K | 2,488,360 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2022-02-16 | 2022-02-18 | 34,282 | $3.66 | $125.5K | 2,439,241 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2022-02-16 | 2022-02-18 | 76,893 | — | $0 | 2,473,523 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-13 | 2021-06-14 | 40,892 | $4.45 | $182.0K | 2,396,630 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-11 | 2021-06-14 | 58,317 | $4.45 | $259.5K | 2,437,522 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 474,629 | — | $0 | 474,629 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 248,869 | $4.42 | $1.10M | 2,495,839 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-06-08 | 2021-06-10 | 44,223 | $4.39 | $194.1K | 2,246,970 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-03-01 | 2021-03-03 | 152,763 | — | $0 | 2,357,523 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-03-01 | 2021-03-03 | 66,330 | $4.50 | $298.5K | 2,291,193 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-18 | 2021-02-19 | 250,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 241,960 | $5.00 | $1.21M | 2,204,760 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 17,844 | $5.01 | $89.4K | 2,446,720 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 232,156 | $5.00 | $1.16M | 2,464,564 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-18 | 2021-02-19 | 250,000 | $0.88 | $220.0K | 2,696,720 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-17 | 2021-02-19 | 5,519 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-17 | 2021-02-19 | 5,519 | $4.75 | $26.2K | 2,446,720 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-17 | 2021-02-19 | 5,519 | $2.62 | $14.5K | 2,452,239 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-02-17 | 2021-02-19 | 116,313 | $4.73 | $550.2K | 2,446,720 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-02-17 | 2021-02-19 | 267,878 | — | $0 | 2,563,033 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-10 | 2021-02-10 | 7,278 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-10 | 2021-02-10 | 7,278 | $2.62 | $19.1K | 2,302,433 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-10 | 2021-02-10 | 7,278 | $4.75 | $34.6K | 2,295,155 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-09 | 2021-02-10 | 49,129 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-09 | 2021-02-10 | 49,129 | $2.62 | $128.7K | 2,344,284 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-09 | 2021-02-10 | 49,129 | $4.75 | $233.4K | 2,295,155 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 33,574 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-08 | 2021-02-10 | 33,574 | $4.75 | $159.5K | 2,295,155 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-08 | 2021-02-10 | 33,574 | $2.62 | $88.0K | 2,328,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-13 | 2020-06-15 | 40,892 | $2.78 | $113.7K | 2,295,155 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 776,617 | — | $0 | 776,617 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 402,930 | $2.73 | $1.10M | 2,336,047 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-08 | 2020-06-09 | 44,223 | $3.13 | $138.4K | 1,933,117 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-06-07 | 2020-06-09 | 48,936 | $3.12 | $152.7K | 1,977,340 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2020-02-19 | 2020-02-21 | 90,397 | $3.53 | $319.1K | 2,026,276 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-02-19 | 2020-02-21 | 210,782 | — | $0 | 2,116,673 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-10 | 2019-12-11 | 58,524 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-10 | 2019-12-11 | 58,524 | $3.96 | $231.8K | 1,964,415 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-10 | 2019-12-11 | 58,524 | $4.76 | $278.6K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 100,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 110,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 1,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 97,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 1,000 | $4.75 | $4.8K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 1,000 | $3.96 | $4.0K | 1,906,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 110,000 | $4.58 | $503.8K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 110,000 | $2.94 | $323.4K | 2,015,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 97,000 | $4.62 | $448.1K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 97,000 | $1.66 | $161.0K | 2,002,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 100,000 | $4.68 | $468.0K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 100,000 | $1.52 | $152.0K | 2,005,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-11-11 | 2019-11-13 | 100,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-11-11 | 2019-11-13 | 100,000 | $1.10 | $110.0K | 1,949,336 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-11-11 | 2019-11-13 | 43,445 | $3.77 | $163.8K | 1,905,891 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 567,423 | — | $0 | 567,423 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 282,534 | $2.92 | $825.0K | 1,849,336 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-08 | 2019-06-11 | 44,225 | $2.81 | $124.3K | 1,566,802 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-07 | 2019-06-11 | 48,936 | $2.81 | $137.5K | 1,611,027 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-06-02 | 2019-06-04 | 52,559 | $2.79 | $146.6K | 1,659,963 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2019-02-20 | 2019-02-22 | 72,245 | $3.20 | $231.2K | 1,712,522 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-02-20 | 2019-02-22 | 254,205 | — | $0 | 1,784,767 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2018-08-21 | 2018-08-23 | 43,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2018-08-21 | 2018-08-23 | 43,000 | $3.75 | $161.3K | 1,530,562 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2018-08-21 | 2018-08-23 | 43,000 | $0.47 | $20.2K | 1,573,562 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 591,510 | — | $0 | 591,510 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-06-08 | 2018-06-11 | 305,556 | $2.70 | $825.0K | 1,530,562 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-06-07 | 2018-06-11 | 32,031 | $2.70 | $86.5K | 1,225,006 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-06-02 | 2018-06-05 | 34,402 | $2.69 | $92.5K | 1,257,037 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-05-28 | 2018-05-30 | 13,480 | $2.43 | $32.8K | 1,291,439 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2018-05-11 | 2018-05-14 | 82,500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-05-11 | 2018-05-14 | 30,052 | $2.52 | $75.7K | 1,304,919 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2018-05-11 | 2018-05-14 | 82,500 | $0.85 | $70.1K | 1,334,971 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2018-02-22 | 2018-02-26 | 113,835 | — | $0 | 1,289,472 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2018-02-22 | 2018-02-26 | 37,001 | $2.20 | $81.4K | 1,252,471 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-12-27 | 2016-12-29 | 60,000 | $1.23 | $73.8K | 929,719 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-12-27 | 2016-12-29 | 39,717 | $2.35 | $93.3K | 890,002 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 725,751 | — | $0 | 725,751 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2017-06-07 | 2017-06-09 | 338,115 | $2.66 | $899.4K | 1,175,637 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2017-06-07 | 2017-06-12 | 338,115 | $2.66 | $899.4K | 1,175,637 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-06-02 | 2017-06-09 | 38,034 | $2.57 | $97.7K | 837,522 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-05-29 | 2017-06-09 | 3,390 | $2.51 | $8.5K | 875,556 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-05-28 | 2017-06-09 | 14,903 | $2.51 | $37.4K | 878,946 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-04-05 | 2017-04-05 | 3,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-04-05 | 2017-04-05 | 3,000 | $1.65 | $5.0K | 893,002 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-04-05 | 2017-04-05 | 3,000 | $3.00 | $9.0K | 890,002 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-04-04 | 2017-04-05 | 37,000 | — | $0 | 3,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-04-04 | 2017-04-05 | 37,000 | $3.00 | $111.0K | 890,002 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-04-04 | 2017-04-05 | 37,000 | $1.65 | $61.0K | 927,002 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2017-02-22 | 2017-06-09 | 1,763 | $2.37 | $4.2K | 893,849 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2017-02-22 | 2017-06-09 | 5,612 | — | $0 | 895,612 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2016-12-27 | 2016-12-29 | 60,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2016-06-30 | 2016-06-30 | 11,223 | $1.05 | $11.8K | 869,719 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 773,700 | — | $0 | 773,700 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2016-06-02 | 2016-06-06 | 363,150 | $1.12 | $406.7K | 858,496 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2016-05-31 | 2016-06-01 | 3,389 | $0.92 | $3.1K | 495,346 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2016-05-31 | 2016-06-01 | 14,903 | $0.92 | $13.7K | 498,735 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2016-05-31 | 2016-06-01 | 3,526 | $0.86 | $3.0K | 513,638 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-18 | 60,000 | $0.72 | $43.2K | 517,164 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-03-10 | 2016-03-11 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 288,786 | — | $0 | 288,786 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-05-28 | 2015-06-01 | 3,389 | $2.18 | $7.4K | 314,870 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2015-05-28 | 2015-06-01 | 142,294 | — | $0 | 457,164 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-05-21 | 2015-06-01 | 3,526 | $2.10 | $7.4K | 318,259 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-03-10 | 2015-03-12 | 95,500 | — | $0 | 95,500 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2015-02-10 | 2015-02-12 | 12,519 | — | $0 | 331,398 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-02-10 | 2015-02-12 | 4,779 | $2.36 | $11.3K | 326,619 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2015-02-10 | 2015-03-12 | 12,519 | — | $0 | 360,234 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2015-02-10 | 2015-03-12 | 4,779 | $2.36 | $11.3K | 355,455 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 56,300 | — | $0 | 1,169,982 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 32,362 | — | $0 | 441,005 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-05-29 | 2014-06-02 | 64,725 | — | $0 | 408,643 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2014-05-21 | 2015-03-12 | 3,526 | $2.97 | $10.5K | 340,392 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2014-02-11 | 2014-02-13 | 3,484 | $4.45 | $15.5K | 376,670 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2014-02-11 | 2014-02-13 | 11,236 | — | $0 | 380,154 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2014-02-11 | 2014-02-13 | 25,000 | — | $0 | 351,670 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2014-02-11 | 2014-02-13 | 7,752 | $4.45 | $34.5K | 343,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-10 | 2014-01-14 | 10,000 | — | $0 | 1,113,682 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-10 | 2014-01-14 | 10,000 | $0.47 | $4.7K | 378,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2014-01-10 | 2014-01-14 | 10,000 | $5.00 | $50.0K | 368,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-10-14 | 2013-10-16 | 22,000 | — | $0 | 1,123,682 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-10-14 | 2013-10-16 | 22,000 | $5.05 | $111.1K | 368,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-10-14 | 2013-10-16 | 22,000 | $0.47 | $10.3K | 390,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-06-04 | 2013-06-05 | 28,600 | — | $0 | 1,145,682 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-04 | 2013-06-05 | 28,600 | $4.03 | $115.3K | 368,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-06-04 | 2013-06-05 | 28,600 | $0.47 | $13.4K | 397,518 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-06-03 | 2013-06-05 | 86,400 | — | $0 | 1,174,282 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-06-03 | 2013-06-05 | 86,400 | $0.47 | $40.6K | 455,318 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-03 | 2013-06-05 | 86,400 | $4.01 | $346.5K | 368,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2013-05-22 | 2013-05-24 | 59,524 | — | $0 | 1,260,682 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 33,670 | — | $0 | 335,248 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 33,670 | — | $0 | 368,918 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-05-06 | 2013-05-08 | 10,000 | — | $0 | 1,201,158 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-05-06 | 2013-05-08 | 10,000 | $0.47 | $4.7K | 311,578 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-05-06 | 2013-05-08 | 10,000 | $4.02 | $40.2K | 301,578 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-01-08 | 2013-01-10 | 25,000 | — | $0 | 1,211,158 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-01-08 | 2013-01-10 | 25,000 | $0.47 | $11.8K | 335,270 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-01-08 | 2013-01-10 | 25,000 | $4.01 | $100.3K | 310,270 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-12-04 | 2012-12-06 | 25,000 | — | $0 | 1,236,158 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2012-12-04 | 2012-12-06 | 25,000 | $4.00 | $100.0K | 310,270 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-12-04 | 2012-12-06 | 25,000 | $0.47 | $11.8K | 335,270 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2012-07-06 | 2012-07-10 | 21,658 | — | $0 | 1,261,158 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2012-07-06 | 2012-07-10 | 25,039 | — | $0 | 310,270 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award deriv | 2012-05-17 | 2012-05-21 | 110,000 | — | $0 | 1,239,500 | SEC↗ |